IWC
ABOS icon

Integrated Wealth Concepts’s Acumen Pharmaceuticals ABOS Stock Holding History

Integrated Wealth Concepts’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.2K Hold
10,179
– – ﹤0.01% 3840
2026
Q1 		$24K Buy
+10,179
New +$26K ﹤0.01% 2253
2025
Q4 		– Sell
-10,179
Closed -$17.4K – 1604
2025
Q3 		$17.4K Sell
10,179
-247
-2% -$342 ﹤0.01% 1971
2025
Q2 		$12.1K Sell
10,426
-4,793
-31% -$5.15K ﹤0.01% 1894
2025
Q1 		$16.7K Buy
15,219
+5,119
+51% +$7.31K ﹤0.01% 1721
2024
Q4 		$17.4K Buy
+10,100
New +$24.3K ﹤0.01% 1706
2024
Q2 		– Sell
-10,100
Closed -$40.9K – 1644
2024
Q1 		$40.9K Sell
10,100
-4,500
-31% -$17K ﹤0.01% 1621
2023
Q4 		$56.1K Buy
14,600
+1,000
+7% +$2.97K ﹤0.01% 1555
2023
Q3 		$56.4K Buy
+13,600
New +$84K ﹤0.01% 1508

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $1.12B AUM 41.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Integrated Wealth Concepts's ABOS Position: Q2 2026 in Review

Integrated Wealth Concepts held its Acumen Pharmaceuticals (ABOS) position steady in Q2 2026 at 10,179 shares worth $27.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3840.

Integrated Wealth Concepts first reported a position in ABOS in Q3 2023 and has held it in 9 quarters since. The position peaked at $56.4K in Q3 2023. 96 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

  • Integrated Wealth Concepts held 10,179 shares of Acumen Pharmaceuticals worth $27.2K as of Q2 2026.
  • Integrated Wealth Concepts left its Acumen Pharmaceuticals share count unchanged in Q2 2026.
  • Acumen Pharmaceuticals made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #3840 holding.
  • Integrated Wealth Concepts first reported a position in Acumen Pharmaceuticals in Q3 2023 and has held it in 9 quarters since.
  • Integrated Wealth Concepts's Acumen Pharmaceuticals position peaked at $56.4K in Q3 2023.
  • 96 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.